This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Press Centre
Alcyomics® to Transform Drug Discovery for Osteoarthritis Treatment With Unique In Vitro Bio-Printed 3D Tissue Model.
Newcastle upon Tyne, 26 January, 2023. Alcyomics Limited® announces it is seeking partners to participate in validation tests of its unique in vitro 3D bio-printed Osteoarthritis tissue model.
Read more
Understanding the downsides to animal testing
Animal testing has been, and largely continues to be, a gold standard to test both the efficacy and safety of new pharmaceuticals and therapeutics.
Read more
July Blog 2022 - Immunotoxicity assessment criteria
Immunotoxicity assessment is a huge consideration when developing a new pharmaceutical intended for use in humans. Are 2D cell based systems enough to truly model immunotoxicity?
Read more
JSIT poster sneak peak
Why not also join our mailing list so we can keep you updated with all our exciting news!
Read more
Skimune Nerve - Peripheral neurotoxicity assay
Alcyomics ® has developed a 3D tissue model based in an inert polyHIPE scaffold that enables the culture of multiple cell lineages together in one system.
Read more1
2
3
4
Next »